Search

… ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit LEIDEN, Netherlands & CAMBRIDGE, Mass., …

… Lilly and ProQR to Expand RNA Editing Collaboration New agreement supports the … in September 2021, applied ProQR’s proprietary Axiomer® RNA editing platform to target disorders of the liver and …

… Leading Intellectual Property Estate for ADAR-mediated RNA Editing LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 06, … US patent No. 11,781,134  that relates to a method for RNA editing. Key claims in this patent pertain to use of any …

… ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform LEIDEN, Netherlands & CAMBRIDGE, Mass., … call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the recently …

… ProQR to Present its Axiomer® RNA Editing Technology at TIDES USA 2023 LEIDEN, Netherlands … RNA therapies based on its proprietary Axiomer ® RNA editing technology platform, today announced a …

… Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event Initial pipeline … RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced initial …

… Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 Platform demonstrates … RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today highlighted key …

… ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide … ® EONs are designed to recruit an endogenously expressed RNA editing system called ADAR (Adenosine Deaminase Acting on …

… ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide …

… Defense of a Key Axiomer® Patent Protecting ADAR-mediated RNA Editing LEIDEN, Netherlands & CAMBRIDGE, Mass., March 14, … invests in expanding its IP estate around ADAR-mediated RNA editing.  “ProQR owns a robust intellectual property …